Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-004307

Options or other derivatives

  • Head of Corporate Development acquired 5,405 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Keeney Adam Head of Corporate Development 2024-02-07 Grant or award · Restricted Stock Unit +5,405 5,405 D: show line 1 in the form
Loading xslF345X05/form4.xml…